MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Hematology
Children
*Architects: BioPharmaceuticals (Hematologic, Hemophilia, Blood Diseases & Disorders)
*Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology _ Leukemia, Hematologic, Blood
*Driving Forces: Hematology & Blood
*Funding: Hematological & Blood Disease_Foundations & Philanthropy Funding
*Global pharmaceutical company focused on women's health, diagnostic imaging, specialized therapeutics, hematology, cardiology, o
2017: VA_65--GE Healthcare, Inc. 65IB Drugs, Pharmaceuticals and Hematology related products Contract Award
2017: VA_65--INO Therapeutics, LLC (65IB) 65IB Drugs, Pharmaceuticals and Hematology related products September 15, 2016
2018: Geron Reports Imetelstat Oral Presentation at European Hematology Association Congress_seekingalpha.com
2018: VA_65--GlaxoSmithKline Consumer Healthcare, LP (65IB) 65IB Drugs, Pharmaceuticals and Hematology related products
2021: NIH_New Directions in Hematology Research (SHINE-II) (R01 Clinical Trial Optional)
2022: NIH_PAS-19-105 _ Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)
2022: VA_65--65IB Drugs, Pharmaceuticals and Hematology related products November 1, 2017 - October 31, 2022
2022: Veru (VERU) Presents At Oncology, Hematology & HemeOnc Conference - Slideshow_seekingalpha.com
2024: 66th ASH (American Society of Hematology) Annual Meeting & Exposition, December 7-10, 2024, in San Diego, California
2024: NIDDK_Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed)
2024: NIDDK_Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed)
2024: Sana Biotechnology: SC291 Moving Forward Beyond Hematological Malignancies_ seekingalpha.com
2025: NIDDK_Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C
Beckman Coulter:Products
Clinical Diagnostics
Dan S. Kaufman, M.D., Ph.D., Associate Professor, Medicine, Division of Hematology, Oncology, and Transplantation
Facilitate technological breakthroughs in molecular biology, developmental biology, hematology, oncology, endocrinology, cardiol
Jame Abraham MD, Chair, Department of Hematology and Medical Oncology, Cleveland Clinic (2024)